Design, Synthesis, and Biological Evaluation of Novel 6H-Benzo[c]chromen-6-one Derivatives as Potential Phosphodiesterase II Inhibitors
Keyword(s):
Urolithins (hydroxylated 6H-benzo[c]chromen-6-ones) are the main bioavailable metabolites of ellagic acid (EA), which was shown to be a cognitive enhancer in the treatment of neurodegenerative diseases. As part of this research, a series of alkoxylated 6H-benzo[c]chromen-6-one derivatives were designed and synthesized. Furthermore, their biological activities were evaluated as potential PDE2 inhibitors, and the alkoxylated 6H-benzo[c]chromen-6-one derivative 1f was found to have the optimal inhibitory potential (IC50: 3.67 ± 0.47 μM). It also exhibited comparable activity in comparison to that of BAY 60-7550 in vitro cell level studies.
2014 ◽
Vol 57
(17)
◽
pp. 7367-7381
◽
2019 ◽
pp. 300-307
2016 ◽
Vol 71
(3)
◽
pp. 205-210
◽
2019 ◽
Vol 15
(5)
◽
pp. 521-536
◽
2008 ◽
Vol 16
(9)
◽
pp. 4810-4822
◽
Keyword(s):